{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:16:11Z","timestamp":1789042571560,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00693","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T10:38:31Z","timestamp":1561113511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":85,"title":["Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by A\u03b21-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-\u03b21"],"prefix":"10.3389","volume":"10","author":[{"given":"Sebastiano Alfio","family":"Torrisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Tropea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Fidilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Tascedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Palmeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Puzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","journal-title":"J. Cell Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2174\/13816128113199990497","article-title":"In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches","volume":"20","author":"Balducci","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1523\/JNEUROSCI.5289-06.2007","article-title":"Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex","volume":"27","author":"Barker","year":"2007","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00213-016-4214-0","article-title":"Role of neuro-immunological factors in the pathophysiology of mood disorders","volume":"233","author":"Bhattacharya","year":"2016","journal-title":"Psychopharmacology (Berl)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1101\/lm.1650110","article-title":"Object recognition memory and the rodent hippocampus","volume":"17","author":"Broadbent","year":"2009","journal-title":"Learn. Mem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2174\/1567205014666170829100100","article-title":"Modulation of inflammation as a way of delaying Alzheimer\u2019s disease progression: the diet\u2019s role","volume":"15","author":"Businaro","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.nbd.2008.01.007","article-title":"TGF-\u03b21 protects against A\u03b2-neurotoxicity via the phosphatidylinositol-3-kinase pathway","volume":"30","author":"Caraci","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1755-5949.2009.00115.x","article-title":"TGF-\u03b21 pathway as a new target for neuroprotection in Alzheimer\u2019s disease","volume":"17","author":"Caraci","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.euroneuro.2011.08.006","article-title":"The CC genotype of transforming growth factor-\u03b21 increases the risk of late-onset Alzheimer\u2019s disease and is associated with AD-related depression","volume":"22","author":"Caraci","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/srep11252","article-title":"A key role for TGF-\u03b21 in hippocampal synaptic plasticity and memory","volume":"5","author":"Caraci","year":"2015","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fphar.2016.00389","article-title":"Fluoxetine prevents A\u03b2(1-42)-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-\u03b21","volume":"7","author":"Caraci","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pneurobio.2018.12.004","article-title":"Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders","volume":"175","author":"Caruso","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010064","article-title":"Carnosine prevents A\u03b2-induced oxidative stress and inflammation in microglial cells: a key role of TGF-\u03b21","volume":"8","author":"Caruso","year":"2019","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8.10A.1","DOI":"10.1002\/0471142301.ns0810as55","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Castagn\u00e9","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.euroneuro.2015.04.006","article-title":"5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine","volume":"25","author":"Casta\u00f1\u00e9","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-142931","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"45","author":"Chung","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.bbi.2011.05.007","article-title":"Early and adult hippocampal TGF-\u03b21 overexpression have opposite effects on behavior","volume":"25","author":"Depino","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1523\/JNEUROSCI.3351-16.2017","article-title":"Astrocyte transforming growth factor beta 1 protects synapses against A\u03b2 oligomers in Alzheimer\u2019s disease model","volume":"37","author":"Diniz","year":"2017","journal-title":"J. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.neurobiolaging.2015.03.005","article-title":"Acute amnestic encephalopathy in amyloid-\u03b2 oligomer-injected mice is due to their widespread diffusion in vivo","volume":"36","author":"Epelbaum","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.neurobiolaging.2011.01.007","article-title":"Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer\u2019s disease","volume":"33","author":"Ferretti","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer\u2019s disease-affected brain: presence of oligomeric Abeta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neuropharm.2018.06.002","article-title":"Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer\u2019s disease","volume":"138","author":"Gulisano","year":"2018","journal-title":"Neuropharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1007\/s12035-016-9952-9","article-title":"Long-term ameliorative effects of the antidepressant fluoxetine exposure on cognitive deficits in 3\u00d7\u2005TgAD mice","volume":"54","author":"Jin","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/YCO.0b013e328356c368","article-title":"Depression and the risk for dementia","volume":"25","author":"Kessing","year":"2012","journal-title":"Curr. Opin. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2008.11.020","article-title":"Antidepressants and dementia","volume":"117","author":"Kessing","year":"2009","journal-title":"J. Affect. Disord."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-129039","article-title":"Synaptotoxic amyloid-\u03b2 oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer\u2019s disease","volume":"33","author":"Klein","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pnpbp.2017.05.007","article-title":"Molecular imaging of neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment","volume":"80","author":"Knezevic","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement (N Y)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000492489","article-title":"Late-life depression versus amnestic mild cognitive impairment: Alzheimer\u2019s disease incidence in 4 years of follow-up","volume":"46","author":"Lauriola","year":"2018","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-\u03b2 oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.intimp.2006.03.015","article-title":"The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder","volume":"6","author":"Lee","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2016.02.007","article-title":"The antineoplastic drug flavopiridol reverses memory impairment induced by amyloid-\u03b21-42 oligomers in mice","volume":"106","author":"Leggio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/ijnp\/pyx004","article-title":"Distinct antidepressant-like and cognitive effects of antidepressants with different mechanisms of action in middle-aged female mice","volume":"20","author":"Li","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2015.05.013","article-title":"Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice","volume":"135","author":"Li","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13550-017-0273-4","article-title":"Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study","volume":"7","author":"Li","year":"2017","journal-title":"EJNMMI Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"27676","DOI":"10.18632\/oncotarget.15398","article-title":"Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe\/PSEN1dE9 double transgenic Alzheimer\u2019s disease mice","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"B41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw055","article-title":"The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials","volume":"19","author":"McIntyre","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.8.1290","article-title":"Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study","volume":"61","author":"Modrego","year":"2004","journal-title":"Arch. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2016.08.002","article-title":"Early effects of Abeta1-42 oligomers injection in mice: involvement of PI3K\/Akt\/GSK3 and MAPK\/ERK1\/2 pathways","volume":"314","author":"Morroni","year":"2016","journal-title":"Behav. Brain. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"M\u00f8rk","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/JCP.0b013e31802e0002","article-title":"Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind placebo-controlled, clinical trial","volume":"27","author":"Mowla","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2017.06.018","article-title":"Synaptic dysfunction in Alzheimer\u2019s disease: from the role of amyloid \u03b2-peptide to the \u03b1-secretase ADAM10","volume":"817","author":"Musardo","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jad.2011.05.047","article-title":"Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression\u2014no influence of celecoxib treatment","volume":"134","author":"Musil","year":"2011","journal-title":"J. Affect. Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0706743718772514","article-title":"Can animal models inform on the relationship between depression and Alzheimer disease","volume":"64","author":"Nyarko","year":"2019","journal-title":"Can. J. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fphar.2018.00162","article-title":"Vortioxetine treatment reverses subchronic PCP treatment-induced cognitive impairments: a potential role for serotonin receptor-mediated regulation of GABA neurotransmission","volume":"9","author":"Pehrson","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2014.07.044","article-title":"Treatment of cognitive dysfunction in major depressive disorder\u2014a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin\u2013norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine","volume":"753","author":"Pehrson","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"\u201cBehavioural despair\u201d in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pnpbp.2017.05.004","article-title":"Antidepressant drugs for beta amyloid-induced depression: a new standpoint","volume":"78","author":"Schiavone","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.08.037","article-title":"Fluoxetine administration during adolescence attenuates cognitive and synaptic deficits in adult 3\u00d7 TgAD mice","volume":"126","author":"Sun","year":"2017","journal-title":"Neuropharmacology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin. Dev. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer\u2019s pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.euroneuro.2016.03.007","article-title":"A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults","volume":"26","author":"Thase","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/FBP.0b013e3282ee2a91","article-title":"Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks","volume":"18","author":"Valluzzi","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.neuroscience.2016.05.051","article-title":"Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria","volume":"330","author":"Villa","year":"2016","journal-title":"Neuroscience"},{"key":"B61","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1567205011666140812114715","article-title":"Fluoxetine improves behavioral performance by suppressing the production of soluble \u03b2-amyloid in APP\/PS1 mice","volume":"11","author":"Wang","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuropharm.2014.10.015","article-title":"Involvement of 5-HT7 receptors in vortioxetine\u2019s modulation of circadian rhythms and episodic memory in rodents","volume":"89","author":"Westrich","year":"2015","journal-title":"Neuropharmacology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bbi.2018.06.018","article-title":"Neuroprotective effects of INT-777 against Abeta1-42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice","volume":"73","author":"Wu","year":"2018","journal-title":"Brain. Behav. Immun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/gps.4409","article-title":"High amyloid-\u03b2 deposition related to depressive symptoms in older individuals with normal cognition: a pilot study","volume":"31","author":"Yasuno","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T10:38:33Z","timestamp":1561113513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":64,"alternative-id":["10.3389\/fphar.2019.00693"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00693","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"article-number":"693"}}